HCA Healthcare (NYSE:HCA – Get Free Report) had its target price lowered by research analysts at Barclays from $402.00 to $387.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Barclays‘s target price would suggest a potential upside of 1.23% from the stock’s current price.
Several other research firms also recently commented on HCA. Oppenheimer decreased their price objective on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. Jefferies Financial Group set a $450.00 target price on shares of HCA Healthcare in a research note on Tuesday, July 14th. Royal Bank Of Canada reduced their price objective on shares of HCA Healthcare from $534.00 to $435.00 and set an “outperform” rating for the company in a research note on Wednesday, July 15th. Wells Fargo & Company set a $369.00 target price on shares of HCA Healthcare in a report on Monday, July 20th. Finally, Stephens lowered their price objective on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a research report on Monday, April 27th. Fourteen investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $480.55.
Check Out Our Latest Stock Report on HCA Healthcare
HCA Healthcare Trading Up 0.0%
HCA Healthcare (NYSE:HCA – Get Free Report) last posted its quarterly earnings data on Friday, July 24th. The company reported $7.59 EPS for the quarter, topping the consensus estimate of $7.56 by $0.03. The firm had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.HCA Healthcare’s revenue was up 8.7% on a year-over-year basis. During the same period in the prior year, the business posted $6.84 EPS. Equities analysts forecast that HCA Healthcare will post 29.19 earnings per share for the current fiscal year.
Hedge Funds Weigh In On HCA Healthcare
Several institutional investors have recently added to or reduced their stakes in the company. Brighton Jones LLC bought a new stake in HCA Healthcare in the 4th quarter worth approximately $1,021,000. NewEdge Advisors LLC increased its position in HCA Healthcare by 11.9% in the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after purchasing an additional 409 shares during the last quarter. Sivia Capital Partners LLC lifted its position in HCA Healthcare by 5.5% during the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock valued at $241,000 after purchasing an additional 33 shares during the last quarter. Jump Financial LLC bought a new stake in shares of HCA Healthcare in the 2nd quarter worth about $2,073,000. Finally, Sei Investments Co. lifted its holdings in shares of HCA Healthcare by 56.3% in the 2nd quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock valued at $52,328,000 after acquiring an additional 49,214 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.
HCA Healthcare Company Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Featured Articles
- Five stocks we like better than HCA Healthcare
- These 3 AI Winners Don’t Sell the Tech—They Use It
- RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade?
- These 4 Earnings Reports Expose the Market’s Growing Economic Divide
- Broadcom May Be the Biggest Winner From Alphabet’s Earnings
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
